The global induction sealing machine market is expected to reach US$ 2.15 billion by 2032, growing at a CAGR of 6% from a valuation of US$ 1.2 billion in 2022, according to a report by FMI. This growth is fueled by the increasing demand for tamper-evident and leak-proof packaging solutions across various industries.
Technology Adoption in Packaging: The packaging industry is rapidly embracing technology, and induction sealing is emerging as a preferred solution due to its efficiency and reliability.
Dominant Applications: Induction sealing machines are widely used in the food and beverage, pharmaceutical, and personal care & cosmetics sectors.
Focus on Counterfeit Protection: The rising concerns about counterfeit products in the pharmaceutical and cosmetics industries are driving the demand for induction sealing machines.
Induction Sealing: A Secure and Efficient Solution
Electromagnetic Induction Technology: Induction sealing uses electromagnetic fields to heat a special seal under the cap liner, creating a tamper-evident bond with the bottle or container.
Enhanced Shelf Life: Induction sealing protects products from contamination and extends their shelf life, minimizing spoilage and waste.
Leak-Proof Security: This technology offers superior leak-proof protection, ensuring product integrity during transportation and storage.
Market Growth Drivers:
Growing Demand for Tamper-Evident Packaging: The increasing need for counterfeit protection and product security is driving the adoption of induction sealing machines.
Shifting Manufacturing Landscape: The trend of manufacturing moving from developed regions to Asia Pacific is creating new market opportunities.
Growing Middle Class Population: The rising disposable income in emerging economies is fueling the demand for packaged food, beverages, and consumer goods, which require secure packaging solutions.
Regional Outlook:
Asia Pacific Leads the Market: The Asia Pacific region is expected to dominate the induction sealing machine market due to its large middle-class population and booming manufacturing sector.
Strong Presence in North America and Europe: Established markets like North America and Europe have a high concentration of manufacturers offering advanced induction sealing solutions.
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
The global transport packaging market is expected to reach US$ 42.76 billion by 2032, growing at a CAGR of 5% from US$ 26.25 billion in 2022, according to a report by FMI. This growth is fueled by the booming e-commerce sector and a growing focus on sustainable packaging solutions.
Market Growth Drivers:
E-commerce Boom: The surge in online shopping is driving the demand for secure and protective packaging solutions for product delivery.
Innovation in Packaging Materials: Manufacturers are developing high-quality, recyclable cardboard and other sustainable packaging solutions.
Growth of Key Industries: The thriving automotive, construction, and pharmaceutical industries are propelling the demand for transport packaging solutions.
Critical Role in Supply-Demand Chain: Transport packaging plays an essential role in ensuring the safe shipping of products by shielding them from contamination during transit and warehousing. It focuses on packaging needs for commodities while they are in transit, especially when transported by road or rail overland.
Protection Against Adverse Conditions: The packaging used during transportation is designed to protect goods from hazards such as extreme weather conditions, heavy rain, and humidity. Packaging manufacturers develop products based on regional circumstances to ensure optimal protection.
Returnable Transport Packaging: Several firms produce and utilize returnable transport packaging products, which are advantageous for both producers and vendors/customers by lowering costs and enhancing product security and safety. For instance, automobile manufacturers frequently use returnable packaging to transport partially finished and fully finished vehicle parts, creating a need for strong, efficient, and long-lasting packaging goods.
Sustainable and Innovative Packaging Solutions:
Environmental Sustainability: International manufacturers are increasingly providing environmentally friendly packaging options and services. These sustainable approaches aim to make reusable packaging more effective, enhance product flow, and reduce overall packaging costs, thus reducing the amount of packaging waste in landfills.
Legal Pressure and Brand Reputation: As legal pressure over the usage of plastic packaging increases, manufacturers are leveraging the opportunity presented by the growing adoption of sustainable packaging solutions to boost their brand reputation.
Recyclable and Lightweight Materials: Utilizing cutting-edge innovation and in-house developed technology, large package manufacturers are creating high-quality, 100% recyclable laminated compact carton board products. These products use carton board, a robust and lightweight material that helps cut CO2 emissions and enhance brand image. Manufacturers assist end-users in securing and optimizing their shipments, resulting in cost savings and other advantages for the entire logistical chain.
Recyclable Foam and Unique Containers: Many manufacturers are focusing on creating recyclable foam made of eco-friendly fibers to replace polymer foams, providing brand owners with sustainable packaging options. Additionally, some producers are developing unique containers for the export of oils, gradually replacing metal drums as the primary container for palm and coconut oils.
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
The Endoscopic Ultrasound Needles Market is on track for a consistent rise, according to a recent analysis by Future Market Insights (FMI). The market, valued at US$180.2 million in 2022, is expected to reach US$223.5 million by 2027. This trajectory translates to a Compound Annual Growth Rate (CAGR) of 4.4% over the forecast period, indicating a promising outlook for the industry.
Endoscopic ultrasound needles are becoming increasingly vital in the medical field, offering minimally invasive procedures and innovative products for fine needle aspiration (FNA) and fine needle biopsy (FNB) for solid lesions. This progress underscores their widespread acceptance among surgeons and healthcare professionals as a safe and effective method, contributing significantly to the growth of the Global Endoscopic Ultrasound needle industry.
Manufacturers in the Global Endoscopic Ultrasound Needles Industry are focusing on new product launches for more precise diagnosis of tissues collected using needles. Gaining a greater share in the endoscopic ultrasound needles market with a diverse portfolio is one of the key strategies of leading players.
As per the report, companies in the Global Endoscopic Ultrasound needle industry are also focusing on collaborating for the development and distribution of advanced endoscopic ultrasound needle products. Key players in the endoscopic ultrasound needles market are focusing on new product development in emerging regions including Latin America and Asia Pacific owing to the increasing prevalence of cancer and other chronic diseases. Endoscopic Ultrasound-Guided Fine Needle Aspiration to Gain Popularity with Rise in Gastrointestinal Diseases
According to the FMI report, Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) is likely to account for the largest share of the endoscopic ultrasound needles market. EUS-FNA gaining popularity for the diagnosis of gastrointestinal diseases and peri-gastrointestinal lesions. The wide application of FNA has also accelerated the growth in the endoscopic ultrasound needles market.
With the growing demand for minimally invasive procedures, doctors and surgeons are using EUS combined with FNA to collect sample fluid and tissue from the chest and abdomen for diagnosis. It has also emerged as an alternative to exploratory procedure.
Meanwhile, in recent years studies conducted on Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) have shown some promising results. As per the FMI study on the endoscopic ultrasound needles market, FNB is emerging as a novel tool in diagnosis by providing information on tissue architecture.
As per the study, ambulatory surgical centers will use endoscopic ultrasound needles on a large scale owing to the rise in the number of these centers and the increasing number of endoscopic ultrasound surgeries performed in ambulatory surgical centers. Being the minimally invasive and non-surgical procedure that can be performed through the colon or upper GI tract, ambulatory surgical centers are gaining traction in the Global Endoscopic Ultrasound needle industry.
Moreover, endoscopic ultrasound is generally considered safe when performed at ambulatory surgical centers with expert healthcare teams. Various healthcare organizations are building ambulatory surgical centers within the premises of the healthcare facility offering a wide range of services with technological advancements to achieve economies of scale.
An increasing number of ambulatory surgical centers are offering safe, cost-effective services, especially for gastroenterology, thereby, driving the demand in the Global Endoscopic Ultrasound Needles Industry.
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Be astounded about meeting people in person. Do n’t let the safety of meeting someone through an app prevent you from going out with people in person! This might result in a more grounded and lasting link than a single that begins with excessive texting.
Build a report that appeals to you and stands out from different consumers. Incorporate a variety of pictures, and read an interesting bio that conveys your personality. Use a great camera when recording your cv, as it will sound more healthy and clear. Avoid using acronyms or other difficult-to-read texting jargon when communicating with your crush, and always have your information proofread before sending.
Keep in mind that she is perhaps just as anxious as you are. Before meeting up in person, it’s important to invest some time getting to know each other. When you’re ready, suggest meeting up for some coffee or lunch. Choose a location where you can fulfill in order to feel comfortable and secure.
If you’re looking for a severe relationship, regard trying out intercontinental dating websites that specialize in long-term connections. These websites have verified users who can find the ideal partner for someone in search of passion. These places include Sofiadate, Theluckydate, Bravodate, and Ukrainiancharm.
When you’ve found a woman who shares your goals and interests, it’s time to move things along. Asking her out on a day is the best way to go about doing this, though there are many methods to do it. Select a fun exercise that will make both of you happy.
If she agrees, set a time and date that are easy for her. Give her some time in advance so she can make plans to work around your routine. In order to find out whether she is enjoying herself on your day, be sure to pay attention to her body language and facial expressions during the duration of your relationship.
Finding a roommate web can be challenging, but it is possible with the right approach. Try to be open-minded and reach out to a lot of ladies, even if you do n’t experience romantically attracted to them first. And recollect, you can always shift up your method if it’s not working for you! Be patient and keep trying, and you’ll be able to find the woman of your ambitions. Nice chance!
The Allergy Immunotherapy Market is poised for a remarkable expansion, driven by a growing public awareness of allergies and a rising prevalence of allergic conditions. According to a recent market analysis by Future Market Insights (FMI), a leading market research firm, the market is expected to surge from an estimated US$1.74 billion in 2023 to a staggering US$4.07 billion by 2033. This translates to a robust Compound Annual Growth Rate (CAGR) of 8.9%, signifying a significant shift towards long-term allergy solutions.
The burgeoning allergy immunotherapy industry is carving its path to success by adopting principles similar to those utilized in immunotherapy treatments for cancer. While the spotlight often shines on cancer immunotherapy for its innovative approaches, it is essential to acknowledge the growing significance of allergy immunotherapy in addressing allergies, which impact millions of individuals worldwide.
This substantial growth trajectory highlights the market’s potential for substantial advancements in allergy treatment, significantly improving the lives of those suffering from allergies. It also underlines the market’s commitment to harnessing the principles of immunotherapy for the greater good, showcasing innovation that extends beyond the realm of cancer treatment.
The predicted revenue growth could be related to the burden of allergy conditions, which are becoming more prevalent globally. The responsibility that complex allergies with increased morbidity place on the healthcare system motivates research and development in this area for the introduction of innovative medicines.
The primary factors propelling the global market are:
The expansion of industrialization and population.
Improvements in healthcare and medicine.
The launch of novel immunotherapeutic medications.
Current regulatory approvals, such as those for oral dissolvable tablets, are further enhanced to gain a larger global allergy immunotherapy industry share.
Compared to other treatments already on the market, sublingual allergy immunotherapy has been clinically shown to be more effective and have fewer adverse effects. Another factor influencing the allergy immunotherapy industry growth is the demographic shift in the population and the macroeconomic environment.
The prevalence of asthma and allergy respiratory illnesses has increased due to rising air pollution levels inside and outside. According to the Asthma and Allergy Association of America (AAFA), rising pollen levels cause more than 25 million allergies.
Europe and North America are the two leading markets for allergy immunotherapy, and they are likely to continue holding a sizable market share during the forecast period. Given the increased awareness, healthcare reimbursement regulations, and growth in the population who suffer from allergies, Europe is estimated to hold a significant portion of the global allergy immunotherapy industry.
“Allergy immunotherapy represents a transformative approach to allergy treatment. This therapeutic method offers long-term relief by desensitizing the immune system to allergens, fundamentally changing how we manage allergies and providing hope for sufferers worldwide.”—by Lead Analyst at Future Market Insights.
Allergy Immunotherapy Market KEY TAKEAWAYS:
The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 9.1% through 2033.
The United States is expected to develop at a 9.1% CAGR during the forecast period.
With a CAGR of 9.3% over the forecast period, Canada is predicted to grow rapidly in the market.
The market in China is expected to increase, registering a CAGR of 8.8% over the forecast period.
Germany is estimated to grow decently, registering a CAGR of 9.7% until 2033.
Top players operating in the allergy immunotherapy market are ALK Abello, Stallergenes Greer, Allergy Therapeutics, Aimmune Therapeutics, Anergis, Arrayit Corporation, Biomay AG, HAL Allergy Group, DBV Technologies, and others.
These key players in the market are developing innovative products, such as sublingual and subcutaneous immunotherapy, to cater to the growing demand for effective allergy treatments. They also invest in research and development to improve existing therapies’ efficacy and safety and expand their market reach through strategic partnerships and collaborations.
Recent Developments from the Allergy Immunotherapy Market:
In September 2021, ALK confirmed that by expanding the number of patients by at least 100,000 yearly, it intends to make allergy testing, immunotherapy treatments, and adrenaline products accessible by 2030.
In June 2021, with the complete restoration of SCIT manufacturing in Antony, Stallergenes Greer declared that Alustal®, its subcutaneous allergen immunotherapy (SCIT) remedy, is now accessible in Italy and Spain.
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
The Benign Prostatic Hyperplasia Prostate Treatment Market is poised for a period of stable expansion, driven by key demographic and technological trends. According to a recent market analysis, the market is currently valued at US$33.03 billion in 2024. Looking ahead, the market is expected to exhibit a steady Compound Annual Growth Rate (CAGR) of 3.6%, reaching a projected valuation of US$47.05 billion by 2034.
One of the key drivers of this remarkable growth is the increasing preference for minimally invasive surgical procedures. Patients and healthcare professionals alike are recognizing the benefits of these approaches, leading to a surge in demand for benign prostatic hyperplasia (BPH) prostate treatment options.
The increasing cases of benign prostatic hyperplasia (BPH) along with a surge in preference for minimally invasive surgeries are primary growth drivers of the target market. Furthermore, the growing popularity of Ayurveda, especially in South Asian countries, will generate more growth-inducing opportunities for the BPH treatment market. Due to all of these considerations, the target market observed a surge in growth rate as it rose to a CAGR of 3.7% from 2013 to 2021.
Heightened emphasis on healthcare, a growing geriatric population, degenerating lifestyle, poor dietary habits, hereditary inheritance of the disease, advancing research and development, and better availability of treatment procedures are some of the prominent factors that positively influence the BPH treatment market growth during the forecast period.
“Rising adoption of minimally invasive procedures coupled with rising incidences of benign prostatic hyperplasia will augment the global growth of the benign prostatic hyperplasia (BPH) prostate treatment market over the forecast period,” says an FMI analyst.
Pfizer Inc., NxThera Inc., NeoTract Inc., Sanofi S.A, GlaxoSmithKline Plc., Allergan Plc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Eli Lily & Company, and Cardinal Health Inc., among others, are some of the major players in the benign prostatic hyperplasia (BPH) prostate treatment market profiled in the full version of the report.
Leading market players are focusing on increasing investment in research and development activities. These participants are keen on offering new treatment options to patients.
More Insights into Benign Prostatic Hyperplasia Prostate Treatment Market Report
In its latest report, FMI offers an unbiased analysis of the Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry, providing historical data from 2013 to 2021 and forecast statistics for 2022 to 2028. To understand the global market potential, growth, and scope, the market is segmented based on treatment type (BPH drugs (alpha-blockers, 5-alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonist (MRA), combination drug), BPH devices (prostatic stents, suture base implant systems, transurethral RF thermal therapy devices)), distribution channel (institutional sales (hospitals, ambulatory surgical clinics, specialty clinics), retail sales (retail pharmacies, drug stores), online pharmacies), and region.
According to the latest FMI reports, based on segmentation, the institutional sales segment leads the market. This segment accounts for 64.7% of the overall market share owing to the rising demand for minimally invasive surgeries. The retail sales segment accounts for 26.7% while the online pharmacies segment holds 8% of the Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry share.
Based on region, the benign prostatic hyperplasia (BPH) prostate treatment market in the United States will exhibit impressive growth during 2022-2028. The rising geriatric population coupled with increasing cases of BPH propel the target market growth in this country. Growth in research and development activities will further aid the target market growth during the projected period. Besides, India’s benign prostatic hyperplasia (BPH) prostate treatment market, too, will present notable growth. This is due to the popularity of Ayurveda as well as a surge in BPH cases. Thus, these two countries will demonstrate significant growth in the benign prostatic hyperplasia (BPH) prostate treatment market during the forecast period.
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
The Gastric Electrical Stimulators Market is poised for a sustained expansion, driven by its growing application in treating gastrointestinal disorders. According to a recent market analysis, the market is projected to reach a valuation of US$433.8 million by 2033. This translates to a steady Compound Annual Growth Rate (CAGR) of 6.1%, indicating a significant rise from its current value of US$240.6 million in 2023
Technological developments: Patients with chronic stomach disorders like gastroparesis now have a more accurate and maybe more successful therapy option because of the development of high-frequency gastric electrical stimulators. This illness results in delayed stomach emptying, which can induce vomiting, nausea, and malnourishment. For the management of these problems, high-frequency stimulators provide a minimally intrusive option.
Management of chronic diseases: There is an increased need for efficient treatment options due to the growing incidence of chronic diseases such as gastroparesis. For patients who have not responded well to conventional drugs or therapy, gastric electrical stimulators offer a dependable and long-term option.
Gastric electrical stimulators are predicted to become more and more in demand due to the growing senior population’s susceptibility to chronic digestive disorders and the growing emphasis on minimally invasive therapies. This pattern, along with continuing technological developments, bodes well for the stomach electrical stimulator industry.
The global gastric electrical stimulator market is expected to reach US$433.8 million by 2033, growing at a CAGR of 6.1% from its 2023 valuation of US$240.6 million.
Advancements in high-frequency stimulators and their effectiveness in managing chronic conditions like gastroparesis are key growth drivers.
The Dynamic Landscape:
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interests of potential buyers and create a larger customer base. For instance,
IntraPace Inc. was established in 2001 to address an unmet need in weight loss surgery by continuing to develop a gentler solution. The company is focusing on gastric pacing devices that use electrical stimulation to influence gut contractions.
Key Developments in the Gastric Electrical Stimulators Market
Medtronic teamed up with Google, a leader in artificial intelligence, to use AI to improve gastric electrical stimulators. This partnership aims to create a cutting-edge stimulator that can adjust to the needs of each patient, potentially revolutionizing the effectiveness and personalization of treatment.
The INSPIRE Control wireless stomach electrical stimulator, introduced by IntraPace in 2021, represented a significant advance in patient-centered technology. This wireless technology offers a more practical and patient-friendly alternative by not requiring invasive surgery for installation or removal, potentially changing the face of stomach electrical stimulation therapy.
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
The Smart Pill Boxes & Bottles Market is on a trajectory for remarkable expansion, driven by a growing emphasis on medication adherence. According to industry estimates, the market value reached US$144.2 million in 2022 and is projected to climb to US$160.2 million by 2023. This initial growth is expected to accelerate further, with a robust Compound Annual Growth Rate (CAGR) of 9.3% anticipated from 2023 to 2033. By the end of 2033, the market is expected to reach a staggering US$388.2 million, highlighting the increasing adoption of these innovative solutions.
Looking Ahead: A Market Poised to Surge
FMI’s analysis forecasts a robust Compound Annual Growth Rate (CAGR) of 9.3% from 2023 to 2033. This upward trend is anticipated to propel the smart pill boxes & bottles market to a staggering US$388.2 million by the end of 2033.
One of the key drivers behind the growth of the smart pill boxes and bottle market is the persistent issue of non-adherence to prescribed medication among adult patients. Studies show that almost 70% of adult patients either discontinue or manipulate their drug therapy, leading to detrimental effects on their health and imposing a significant economic burden on healthcare delivery systems through increased emergency cases and hospitalization.
Smart pill boxes and bottles are increasingly being perceived as a potential solution to such challenges posed by increased healthcare delivery costs. The significance of medication adherence continues to rise with an increasing prevalence of chronic conditions, propelling demand for the Global Smart Pill Boxes And Bottles Industry.
Dementia and geriatric care remain the key application areas of smart pill boxes and bottles, according to the report. More than 80% of sales are accounted for by aging patients and dementia-afflicted populations. Cancer management is likely to emerge lucrative in terms of applicability in the coming years.
With surging demand for high-quality healthcare delivery, senior care centers, hospitals, long-term care centers, and home care settings are accelerating the adoption of medication dispensers, thereby elevating the revenue growth of the smart pill boxes and bottle market. Some of the leading companies are actively involved in the development of advanced technology medication dispensing devices with zero error risks during medication.
Home care settings maintain the highest consumption share in the smart pill boxes and bottles market which roughly equates to 65% of total sales. Almost a fifth of smart pill boxes and bottles sold are installed at senior care and assisted living centers. FMI’s analysis indicates that long-term care centers are also creating promising
market opportunities for Smart Pill Boxes & Bottles Market manufacturers and distributors.
North America continues to reign supreme owing to early adoption of advanced technology-enabled Global Smart Pill Boxes And Bottles Industry, accounting for more than a third of the global market revenue. The European market for smart pill boxes and bottles also represents a substantial volume share, majorly driven by German patients. South and East Asian regions are briskly developing high-potential markets for manufacturers and distributors of smart pill boxes and bottles, says the report.
The vendor landscape of the smart pill boxes and bottles market remains fairly consolidated and competitive, as Tier 1 manufacturers continue to account for a majority of the share in the market in terms of volume. While the dominance of Koninklijke Philips N.V., PharmRight Corporation & Livi, and AdhereTech prevails in the Global Smart Pill Boxes And Bottles Industry, the report finds that the competition among these players is characterized by product innovation, new launches, and technological advancements.
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Anemia Treatment MarketThe Anemia Treatment Market is witnessing a surge in growth, driven by increasing awareness and the need for effective therapies. According to a recent market analysis, the industry surpassed a significant milestone in 2022, reaching a valuation of US$10.0 billion. This positive momentum is expected to continue, with analysts forecasting a robust expansion to a projected market value of US$14.9 billion by 2028. This impressive growth trajectory signifies a CAGR (Compound Annual Growth Rate) of 6.9%, highlighting the growing demand for effective anemia treatments.
According to a recent report released by Future Market Insights, a significant portion of the demand for Anemia therapy can be attributed to cases arising from one or more chronic medical conditions. This underscores the critical role the industry plays in addressing the healthcare needs of individuals facing anemia associated with various chronic ailments.
The demand for Anemia treatment is chiefly driven by chronic kidney disease (CKD), one of the non-communicable chronic diseases contributing to the demographic shift in emerging regions. Additionally, the increasing popularity of combination therapy is poised to make a substantial impact on the Global Anemia Treatment Industry. The growing utilization of antibiotics, metal chelating agents, erythropoietin-stimulating drugs, and vitamin and iron supplements in combination therapy is recognized as a key driver elevating the prospects of the Anemia treatment Industry in the years to come.
Vitamin Supplements Gain Significant Traction for Anemia Treatment
A surge in R&D investments is prominently improving the scope of anemia treatment. Moreover, a rising number of pipeline drugs and the promising potential of biosimilars will contribute to the demand for anemia treatment. However, the high price point associated with biologics continues to mask their superior treatment efficacy over conventional medications.
More than 75% of anemia treatment Industry revenue is accounted by medications, of which, ESAs (erythropoietin stimulating agents) remain bestselling. Blood transfusion is also cited as an important type of anemia treatment, contributing to the market growth. However, the demand for the former is poised for a robust double-digit yearly growth in 2021 and ahead.
The lucrative emergence of ESAs and soaring consumption of other biosimilar medications are likely to introduce new investment opportunities in the Global Anemia Treatment Industry. The extensive availability, accessibility, and economic price point of biosimilar drugs are strongly backed by an increasing number of FDA approvals. This according to FMI will significantly contribute to the improvement of CKD, thereby bolstering the revenue of the anemia treatment Industry. FDA recently issued approval to a biosimilar drug by Pfizer for use in anemia treatment – Retacrit (epoetin alfa-epoxy). Over 55% of dietary supplements consumed as a part of anemia treatment are vitamin supplements. An increasing number of iron-deficient patients will
reportedly result in rapid demand growth for iron supplements in years to come, posing strong competition to those vitamin supplements in the Global Anemia Treatment Industry. Currently, almost 60% of the medications and dietary supplements for anemia treatment are available at institutional pharmacies. The report also points to a gradually expanding share of retail pharmacies shortly.
North American patients raise just under a third of the global demand for anemia treatment, whereas more than a third of the total demand is accounted for collectively by East and South Asia. Europe is also cited as one of the key regional markets for anemia treatment providers.
Product-based Business Models Emerge as a Key Competitive Strategy
The consistent quest for therapeutically effective ESAs, dietary supplements, antibiotics, and other biologics to be used in anemia treatment continues to create attractive avenues in the R&D realm. Leading drug manufacturers are investing efforts in launching novel products and upgrading their existing consumable product portfolios. Amgen’s epoetin alpha has been a breakthrough product since its launch in the CKD treatment landscape and growing adoption continues to benefit the company.
Besides augmenting R&D investments, prominent players in the anemia treatment Industry are also focusing on strategic agreements and partnerships – further paving the way for the development of anemia treatment drugs. The emergence of partnership-based models in the competitive landscape of the anemia treatment market is likely to reshape the R&D structure in the anemia treatment Industry. The report prompts major investment opportunities arising in open collaboration strategies. Several drug manufacturers are also opting for partnerships with regional distribution leaders to form effective product-based distribution channels, particularly targeting developing regional markets.
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
The Dental X-Ray Systems Market is experiencing a surge, fueled by a growing emphasis on oral health and continuous advancements in technology. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is currently valued at approximately US$1.66 billion. This positive trend is expected to hold strong, with the market projected to climb at a robust Compound Annual Growth Rate (CAGR) of 6.4% over the next eight years. By 2030, the dental X-ray systems industry is anticipated to reach an impressive valuation of US$2.73 billion.
The escalating demand for advanced diagnostic tools is a driving force behind this remarkable growth. The surge in demand is primarily fueled by an increasing incidence of acute diseases, such as cancer, emphasizing the need for effective diagnostics and treatment options. Early detection of diseases is crucial for improving the probability of survival, and dental X-ray systems are emerging as promising diagnostic and treatment tools to meet this pressing need.
The rising geriatric population and their edentulous issues directly open lucrative opportunities for the dental X-ray systems market. Moreover, healthcare facilities utilized by the elderly population are subsidized by the government, which in turn, has boosted the usage of dental X-ray systems. A report published by Future Market Insights (FMI) opines that the global dental X-ray systems market will grow at a striking CAGR of over 6% by the end of 2026.
With the increasing comfort provided by portable intraoral X-ray systems, the traditionally used floor-mounted dental X-ray systems are gradually becoming obsolete. When weighted based on cost, dental X-ray systems provide far better affordability to dental clinics and hospitals as compared to cone-beam computed tomography (CBCT) systems, which is why the sales prospects of the former are better.
Challenges To The Dental X-Ray Systems Market: Reduction in Reimbursement
A notable reduction in the primary healthcare facilities for many diseases including oral health will affect the capacity and the resources adversely. Newly formed legislation will enforce reduced reimbursement regulations on the MPFS (Medicare Physician FEE Schedule) and HOPPS (Hospital Outpatient Prospective Payment System), which is expected to cause a drop in the growth of the dental X-ray systems market.
Technological Advancements to Lend Ample Growth Opportunities to the Dental X-Ray Systems Market
Innovations and advancements brought about in the medical imaging vicinity especially, dental X-ray systems have intensified the growth prospects of the dental X-ray systems market. Owing to the progress made by the healthcare industry, there has been a consistent need for the precise diagnosis of diseases, which has been fulfilled by dental X-ray systems. Given the multifold applications of these systems, the Global Dental X-Ray Systems Industry is projected to grow exponentially.
North America to Maintain a Strong Hold on the Dental X-Ray Systems Market
The study on the dental X-ray systems market provides a detailed analysis based on several factors affecting the market growth. The key geographies assessed in this study include China, APEC, Europe, Latin America, North America, and the Middle East and Africa (MEA). Depending on the market size, North America leads the dental X-ray systems market, attributed to its advanced healthcare facilities and excellent spending capacity. As a subsequence, the regional dental X-ray systems market is expected to bear positive results for the global dental X-ray systems market.
Following the footsteps of North America, Europe is the second most dominating region influencing the growth of the dental X-ray systems market. In addition to this, Asia Pacific is equally estimated to contribute to the growing market size during 2018 – 2026.
Collaboration and Mergers to Trigger the Growth of the Dental X-Ray Systems Market
The report on the dental X-ray systems market includes a comprehensive analysis of the companies devising innovative solutions in the market. The leading players incorporated in the report are FONA, J. MORITA CORP., Danaher Corporation, PLANMECA OY, Prexion Corporation, Carestream Dental, LLC, Owandy Radiology, Vatech Co. Ltd., The Yoshida Dental Mfg. Co. Ltd., Dentsply Sirona, LED Medical Diagnostics Inc., Cefla S.C., and Air Techniques, Inc., among others.
Middle East & Africa (MEA) Dental X-ray Systems Market
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
